These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11683964)

  • 1. Topical tacrolimus and cyclosporin A differentially inhibit early and late effector phases of cutaneous delayed-type and immunoglobulin E hypersensitivity.
    Geba GP; Ptak W; Askenase PW
    Immunology; 2001 Oct; 104(2):235-42. PubMed ID: 11683964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical glucocorticoid augments IgE-mediated passive cutaneous anaphylaxis in Balb/C mice and mast cell deficient WBB6F1 v/v mice.
    Katayama I; Igawa K; Minatohara K; Nishioka K
    Clin Exp Allergy; 1997 Dec; 27(12):1477-83. PubMed ID: 9433944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [125I]fibrin deposition occurs at both early and late intervals of IgE-dependent or contact sensitivity reactions elicited in mouse skin. Mast cell-dependent augmentation of fibrin deposition at early intervals in combined IgE-dependent and contact sensitivity reactions.
    Mekori YA; Galli SJ
    J Immunol; 1990 Dec; 145(11):3719-27. PubMed ID: 2246510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (R)-(+)-pulegone suppresses allergic and inflammation responses on 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice model.
    Choi YY; Kim MH; Lee H; Jo SY; Yang WM
    J Dermatol Sci; 2018 Sep; 91(3):292-300. PubMed ID: 29933898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells.
    Ptak W; Herzog WR; Askenase PW
    J Immunol; 1991 Jan; 146(2):469-75. PubMed ID: 1987274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of scratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasone.
    Inagaki N; Shiraishi N; Igeta K; Itoh T; Chikumoto T; Nagao M; Kim JF; Nagai H
    Eur J Pharmacol; 2006 Sep; 546(1-3):189-96. PubMed ID: 16914137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy of tacrolimus and cyclosporine A in a murine model of dinitrofluorobenzene-induced atopic dermatitis.
    Yamashita H; Ito T; Kato H; Asai S; Tanaka H; Nagai H; Inagaki N
    Eur J Pharmacol; 2010 Oct; 645(1-3):171-6. PubMed ID: 20674565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oleanolic acid acetate inhibits atopic dermatitis and allergic contact dermatitis in a murine model.
    Choi JK; Oh HM; Lee S; Park JW; Khang D; Lee SW; Lee WS; Rho MC; Kim SH
    Toxicol Appl Pharmacol; 2013 May; 269(1):72-80. PubMed ID: 23499868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice.
    Lack G; Bradley KL; Hamelmann E; Renz H; Loader J; Leung DY; Larsen G; Gelfand EW
    J Immunol; 1996 Aug; 157(4):1432-9. PubMed ID: 8759723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of the picryl chloride-induced allergic dermatitis model in mouse ear lobes by 12-O-tetradecanoylphorbol 13-acetate, and analysis of the role of histamine in the modified model.
    Hirasawa N; Ohsawa Y; Katoh G; Shibata K; Ishihara K; Seyama T; Tamura S; Hong J; Ohuchi K
    Int Arch Allergy Immunol; 2009; 148(4):279-88. PubMed ID: 19001787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different mechanisms of release of vasoactive amines by mast cells occur in T cell-dependent compared to IgE-dependent cutaneous hypersensitivity responses.
    Van Loveren H; Kraeuter-Kops S; Askenase PW
    Eur J Immunol; 1984 Jan; 14(1):40-7. PubMed ID: 6198182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis.
    Trautmann A; Akdis M; Schmid-Grendelmeier P; Disch R; Bröcker EB; Blaser K; Akdis CA
    J Allergy Clin Immunol; 2001 Nov; 108(5):839-46. PubMed ID: 11692113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effects of combination using glucosamine plus tacrolimus (FK-506) on the development of atopic dermatitis-like skin lesions in NC/Nga mice.
    Kim CH; Cheong KA; Park CD; Lee AY
    Scand J Immunol; 2012 May; 75(5):471-8. PubMed ID: 22023698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FK-506 and cyclosporin A potentiate the IgE antibody production by contact sensitization with hapten in mice.
    Nagai H; Hiyama H; Matsuo A; Ueda Y; Inagaki N; Kawada K
    J Pharmacol Exp Ther; 1997 Oct; 283(1):321-7. PubMed ID: 9336339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A murine model of epicutaneous protein sensitization is useful to study efficacies of topical drugs in atopic dermatitis.
    Lehto M; Savinko T; Wolff H; Kvist PH; Kemp K; Lauerma A; Alenius H
    Int Immunopharmacol; 2010 Apr; 10(4):377-84. PubMed ID: 20074670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective and curative effects of topically applied CX-659S, a novel diaminouracil derivative, on chronic picryl chloride-induced contact hypersensitivity responses.
    Inoue Y; Isobe M; Shiohara T; Goto Y; Hayashi H
    Br J Dermatol; 2002 Oct; 147(4):675-82. PubMed ID: 12366412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pimecrolimus inhibits the elicitation phase but does not suppress the sensitization phase in murine contact hypersensitivity, in contrast to tacrolimus and cyclosporine A.
    Meingassner JG; Fahrngruber H; Bavandi A
    J Invest Dermatol; 2003 Jul; 121(1):77-80. PubMed ID: 12839566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenylbutyrate suppresses distinct skin reactions that are enhanced by blockade of epidermal growth factor receptor signaling.
    Chung YL; Pui NN
    J Dermatol Sci; 2011 Dec; 64(3):163-73. PubMed ID: 21924869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction and modification of anti-TNP reaginic and IgG antibody responses by reactive trinitrophenyl derivatives.
    Thomas WR; Watkins MC; Jouhal SS; Asherson GL
    Immunology; 1978 Oct; 35(4):673-82. PubMed ID: 361549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isotype-like suppression of T cell-mediated immunity in vivo. II. Suppression of the early component of contact sensitivity by a Ly-2+ T cell-derived suppressor factor that binds to contact sensitivity-initiating, antigen-specific, Ly-1+ T cell-derived factors that are of different antigen specificities.
    Ptak W; Bereta M; Ptak M; Askenase PW
    J Immunol; 1986 Mar; 136(5):1564-70. PubMed ID: 2419405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.